Hotchkis & Wiley Capital Management
AMPH icon

Hotchkis & Wiley Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-402,563
Closed -$10.8M – 467
2025
Q4 		$10.8M Buy
402,563
+76,380
+23% +$1.97M 0.03% 218
2025
Q3 		$8.69M Sell
326,183
-39,737
-11% -$1.03M 0.03% 288
2025
Q2 		$8.4M Buy
365,920
+95,770
+35% +$2.38M 0.03% 304
2025
Q1 		$7.83M Buy
270,150
+32,630
+14% +$1.04M 0.03% 285
2024
Q4 		$8.82M Buy
237,520
+14,900
+7% +$681K 0.03% 290
2024
Q3 		$10.8M Buy
+222,620
New +$9.77M 0.04% 212

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Hotchkis & Wiley Capital Management's AMPH Position: Q1 2026 in Review

Hotchkis & Wiley Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 402,563 shares — an estimated $10.8M sold.

Hotchkis & Wiley Capital Management first reported a position in AMPH in Q3 2024 and held it in 6 quarters. The position peaked at $10.8M in Q3 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Hotchkis & Wiley Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 402,563 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $10.8M.
  • Hotchkis & Wiley Capital Management first reported a position in Amphastar Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • Hotchkis & Wiley Capital Management's Amphastar Pharmaceuticals position peaked at $10.8M in Q3 2024.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2026, filed 15 May 2026.